Loss of KMT2D in B cells in mice leads to the development of B-cell lymphomas, indicating that this gene is a bona fide tumor suppressor (Ortega-Molina et al., 2015; Zhang et al., 2015). Here, KMT2D is linked to B-cell non-Hodgkin lymphoma.